Egyptian Heart Journal

Aims & Scope

The Egyptian Heart Journal is the official journal of the Egyptian Society of Cardiology.

It is an international journal that publishes peer-reviewed articles on all aspects of cardiovascular disease, including original clinical studies and translational investigations.

The journal publishes research, review articles, case reports and commentary articles, as well as editorials interpreting and commenting on the research presented.

In addition, it provides a forum for the exchange of information on all aspects of cardiovascular medicine, including educational issues.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• C-reactive protein, inflammation and coronary heart disease

  Citation: 228

  Authors: Amit Kumar, Harsh Vardhan, Arun, Sanjeev Kumar

• Additive manufacturing applications in cardiology: A review

  Citation: 48

  Authors: Abid, Mohd, Anil

• Value of global longitudinal strain by two dimensional speckle tracking echocardiography in predicting coronary artery disease severity

  Citation: 43

  Authors: Hanan, Ekhlas

• Safety and feasibility of complete simultaneous revascularization during primary PCI in patients with STEMI and multi-vessel disease

  Citation: 34

  Authors: Walid, Nabil, Rasha

• Death anxiety in patients with myocardial infarction or cancer

  Citation: 34

  Authors: Ebru, Meliha Zengin, Mehmet Baran, Başak, Can, Tonguç Demir

• Effect of high flow arteriovenous fistula on cardiac function in hemodialysis patients

  Citation: 33

  Authors: Mohamed Ayman, Wael Mahmoud, Viola William, Tamer Wahid

• Risk factors for acute coronary syndrome in patients below the age of 40 years

  Citation: 27

  Authors: Aram J., Abdulsalam Y., Bahar R.

• Incidence and predictors of post-catheterization femoral artery pseudoaneurysms

  Citation: 23

  Authors: Hussein Heshmat, Mahmoud Farouk, Essam Baligh, Soilman Ghareeb

• XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America

  Citation: 21

  Authors: Carlos Arturo Areán, Fernando, Ghazi, Suleiman M., Marc, Marco Antonio Lavagnino, Naser Samih, Alexander G.G.

• The Egyptian Hypertension Society

  Citation: 20

  Authors: